In summary, our study demonstrates that functional multipotent LT-HSCs can be gene-edited using Cas9-AAV6 technology and that beta-globin gene correction in SCD HSCs improves in vivo RBC indices following autologous transplantation. This evidence concerns the gene HBB and Schnyder corneal dystrophy.